More than 24 million Canadians benefit from private drug plan coverage. Private drug plans tend to cover more drugs more quickly when compared to public plans, which helps increase the value of the Canadian market for future pharmaceutical innovation.
Analysis & Reports
The 2021 Cost Drivers report highlights the consistent annual cost growth in the Canadian private drug benefits market and outlines factors that contribute to price increases.
The 2016–2019 Cost Drivers report highlights annual cost growth in the Canadian private drug benefits market and outlines factors that contribute to price increases.
Infographics & Data
The process for Canadians to access new medicines is extremely complex and involves several different federal, provincial, and territorial agencies. It takes two years following approval (732 days) for Canadian patients to get access to a drug in the public plan, whereas those in the private plan get access to a drug in less than one year (226 days).